American Vanguard Corporation (AVD) - Total Liabilities
Based on the latest financial reports, American Vanguard Corporation (AVD) has total liabilities worth $434.02 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore American Vanguard Corporation (AVD) cash flow conversion to assess how effectively this company generates cash.
American Vanguard Corporation - Total Liabilities Trend (1986–2024)
This chart illustrates how American Vanguard Corporation's total liabilities have evolved over time, based on quarterly financial data. Check American Vanguard Corporation liquid asset ratio to evaluate the company's liquid asset resilience ratio.
American Vanguard Corporation Competitors by Total Liabilities
The table below lists competitors of American Vanguard Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pierce Group AB
ST:PIERCE
|
Sweden | Skr452.00 Million |
|
Evermore Chemical Industry Co Ltd
TW:1735
|
Taiwan | NT$1.65 Billion |
|
Immutep Ltd ADR
NASDAQ:IMMP
|
USA | $48.30 Million |
|
EN Shoham Business Ltd
TA:SHOM
|
Israel | ILA910.71 Million |
|
Nova Minerals Limited
NYSE MKT:NVA
|
USA | $1.06 Billion |
|
Prozone Realty Limited
NSE:PROZONER
|
India | Rs7.01 Billion |
|
ISU Abxis Co. Ltd
KQ:086890
|
Korea | ₩45.29 Billion |
|
Yusin Holding Corp
TW:4557
|
Taiwan | NT$2.05 Billion |
Liability Composition Analysis (1986–2024)
This chart breaks down American Vanguard Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see American Vanguard Corporation market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.07 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.96 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how American Vanguard Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for American Vanguard Corporation (1986–2024)
The table below shows the annual total liabilities of American Vanguard Corporation from 1986 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $403.61 Million | +1.53% |
| 2023-12-31 | $397.54 Million | +11.56% |
| 2022-12-31 | $356.33 Million | +10.86% |
| 2021-12-31 | $321.42 Million | +0.58% |
| 2020-12-31 | $319.56 Million | -7.89% |
| 2019-12-31 | $346.93 Million | +31.24% |
| 2018-12-31 | $264.36 Million | +14.80% |
| 2017-12-31 | $230.28 Million | +56.02% |
| 2016-12-31 | $147.60 Million | -15.76% |
| 2015-12-31 | $175.21 Million | -17.42% |
| 2014-12-31 | $212.17 Million | +11.87% |
| 2013-12-31 | $189.65 Million | +8.71% |
| 2012-12-31 | $174.45 Million | +14.72% |
| 2011-12-31 | $152.07 Million | +31.82% |
| 2010-12-31 | $115.36 Million | +13.52% |
| 2009-12-31 | $101.62 Million | -22.42% |
| 2008-12-31 | $130.99 Million | +20.35% |
| 2007-12-31 | $108.84 Million | -23.08% |
| 2006-12-31 | $141.50 Million | +40.41% |
| 2005-12-31 | $100.78 Million | +72.64% |
| 2004-12-31 | $58.37 Million | +3.50% |
| 2003-12-31 | $56.40 Million | +60.20% |
| 2002-12-31 | $35.20 Million | +1.73% |
| 2001-12-31 | $34.61 Million | -5.97% |
| 2000-12-31 | $36.80 Million | +24.72% |
| 1999-12-31 | $29.51 Million | -17.34% |
| 1998-12-31 | $35.70 Million | +5.31% |
| 1997-12-31 | $33.90 Million | +18.53% |
| 1996-12-31 | $28.60 Million | +34.27% |
| 1995-12-31 | $21.30 Million | -17.44% |
| 1994-12-31 | $25.80 Million | +14.67% |
| 1993-12-31 | $22.50 Million | +4.17% |
| 1992-12-31 | $21.60 Million | -3.57% |
| 1991-12-31 | $22.40 Million | +10.34% |
| 1990-12-31 | $20.30 Million | +86.24% |
| 1989-12-31 | $10.90 Million | +39.74% |
| 1988-12-31 | $7.80 Million | +11.43% |
| 1987-12-31 | $7.00 Million | +22.81% |
| 1986-12-31 | $5.70 Million | -- |
About American Vanguard Corporation
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets chemical, biological and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. It synthesizes and formulates chemicals, and ferments and extracts microbial products, including insecticides, fungicides, herbicides, soil health, plant nutrition, mollu… Read more